Download PDF
Thromb Haemost 2001; 85(04): 747-748
DOI: 10.1055/s-0037-1615666
Letters to the Editor
Schattauer GmbH

A Tail Vein Bleeding Time Model and Delayed Bleeding in Hemophiliac Mice

George J. Broze
1   Division of Hematology, Washington University Medical Center, St. Louis, MO, USA
,
Zheng-Feng Yin
1   Division of Hematology, Washington University Medical Center, St. Louis, MO, USA
,
Nina Lasky
1   Division of Hematology, Washington University Medical Center, St. Louis, MO, USA
› Author Affiliations
Further Information

Publication History

Received 06 November 2000

Accepted 13 November 2000

Publication Date:
08 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Dejana E, Callioni A, Quintana A, de Gaetano G. Bleeding time in laboratory animals. II - A comparison of different assay conditions in rats. Thromb Res 1979; 15: 191-7.
    CrossrefPubMedGoogle Scholar
  • 2 Novak Eh, Sweet HO, Prochazka M, Parentis M, Soble R, Reddington M, Cairo A, Swank RT. Cocoa: a new mouse model for platelet storage pool deficiency. Brit J. Haemat. 1988; 69: 371-78.
    CrossrefPubMedGoogle Scholar
  • 3 Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian Jr HH. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia. Nat Genet. 1995; 10: 119-21.
    CrossrefPubMedGoogle Scholar
  • 4 Lin HF, Maeda N, Smithies O, Straight DL, Stafford DW. A coagulation factor IX-deficient mouse model for human hemophilia B. Blood. 1997; 90: 3962-6.
    PubMedGoogle Scholar
  • 5 Gailani D, Lasky NM, Broze Jr GJ. A murine model of factor XI deficiency. Blood Coag Fibrinol. 1997; 8: 134-44.
    CrossrefPubMedGoogle Scholar
  • 6 Yin Z-F, Lasky NM, Broze Jr GJ. Unpublished work 1995
    PubMed
  • 7 Yin Z-F, Huang Z-F, Cui J, Fiehler R, Lasky N, Ginsburg D, Broze Jr GJ. Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci. USA 2000; 97: 6734-8.
    CrossrefPubMedGoogle Scholar
  • 8 Hodivala-Dilke hM, McHugh hP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Cullere M, Ross FP, Coller BS, Teitelbaum S, Hynes RO. Beta3-integrin deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest. 1999; 103: 229-38.
    CrossrefPubMedGoogle Scholar
  • 9 Macarat M, Koffi A, Henocque G, Mathieu J-F, Guilbaud J-C.. Optimized microturbidimetric assay for fibrinogen. Clin Chem. 1989; 35: 211-4.
    PubMedGoogle Scholar
  • 10 Broze Jr GJ, Higuchi DA. Coagulation-dependent inhibition of fibrinolysis: Role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma. Blood. 1996; 88: 3815-23.
    PubMedGoogle Scholar
  • 11 Von dem Borne PA, Bajzar L, Meijers JC, Nesheim ME, Bouma BN. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. J Clin Invest. 1997; 99: 2323-7.
    CrossrefPubMedGoogle Scholar
  • 12 Borchgrevink CF, Waaler BA. The secondary bleeding time. A new method for the differentiation of hemorrhagic diseases. Acta Med Scand. 1958; 162: 361-74.
    PubMedGoogle Scholar